A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer
Clinical trial NCT07441460 · RECRUITING
Trial details
- NCT number
- NCT07441460
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-06
- Primary completion
- 2034-08-07
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.